Product
Intensive lipid-lowering control
1 clinical trial
1 indication
Indication
Coronary Artery Disease ProgressionClinical trial
Effects of Intensive Lipid-lowering on Coronary Atherosclerotic Plaque Phenotype and Major Adverse Cardiovascular Events in Adults With Low to Intermediate 10-year ASCVD Risk: a Prospective, Randomized, Open-label, Blinded Endpoint Analysis(PROBE)Status: Recruiting, Estimated PCD: 2023-12-01